Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Select Medical Hldgs (NYSE:SEM) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:30 PM.
Here's what investors need to know about the announcement.
Select Medical Hldgs beat estimated earnings by 2.86%, reporting an EPS of $0.36 versus an estimate of $0.35.
Revenue was up $78.00 million from the same period last year.
Last quarter the company missed on EPS by $0.03 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Select Medical Hldgs's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | 0.41 | 0.54 | 0.42 | 0.36 |
EPS Actual | 0.38 | 0.61 | 0.56 | 0.22 |
Revenue Estimate | 1.63B | 1.65B | 1.65B | 1.58B |
Revenue Actual | 1.67B | 1.67B | 1.67B | 1.58B |
To track all earnings releases for Select Medical Hldgs visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SEM